-+ 0.00%
-+ 0.00%
-+ 0.00%

IOVANCE’S AMTAGVI® (LIFILEUCEL) GRANTED APPROVAL FOR THE TREATMENT OF ADVANCED MELANOMA IN AUSTRALIA

Reuters·06/03/2026 20:05:00

Please log in to view news